101/163US=57-B / Biol/Mol
Weinberg RA. p53 and apoptosis: master guardian and executioner. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 307-56. ISBN 0-8153-4078-8.

P53; APOPTOSE; PAPOVAVIRUS; MUTANTES DE P53; NATUREZA DAS MUTACOES DO GENE P53; DANO AO DNA; GENOTIPO P53; RESPOSTAS CELULARES A RADIACAO; ACUMULACAO DE P53; CELULAS P53 MUTANTES


102/163US=57-B / Biol/Mol
Weinberg RA. Maintenance of genomic integrity and the development of cancer. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 463-526. ISBN 0-8153-4078-8.

GENOMA; DESENVOLVIMENTO DO CANCER; SIMETRICAS DA CELULA-TRONCO. DIVISOES; ASSIMETRICAS DE CELULAS-TRONCO. DIVISOES; DIFERENCIACAO HEMATOPOETICA; DNA-POLIMERASES; MUTACOES DO GENE P53; AGENTES MUTAGENICOS; AFLATOXINA; FIGADO CARCINOGENESE; AMINA HETEROCICLICA; SINDROME MIELODISPLASICA; XERODERMA PIGMENTOSO


103/163US=7 / Ginecologia
D'Andrilli G, Bovicelli A, Giordano A. The cell cycle and the molecular biology of cancer. In: Giordano A, Bovicelli A, Kurman RJ. Molecular pathology of gynecologic cancer. New Jersey: Humana Press, 2007. p. 3-14. (Current Clinical Oncology) ISBN 978-1-58829-453-1.

CANCER; CICLO CELULAR; BIOLOGIA MOLECULAR; CICLINA E; CICLINA D1; CICLINA D2; CICLINA D3; CDK4; VIA P53; VIA PRB


104/163US=7 / Ginecologia
Masciullo V, Giordano A. Molecular genetics of cervical cancer. In: Giordano A, Bovicelli A, Kurman RJ. Molecular pathology of gynecologic cancer. New Jersey: Humana Press, 2007. p. 113-23. (Current Clinical Oncology) ISBN 978-1-58829-453-1.

CANCER GINECOLOGICO; CANCER CERVICAL; GENETICA MOLECULAR; CICLO CELULAR; HPV; POLIMORFISMO DO P53; HIV; MARCADORES BIOLOGICOS; ANGIOGENESE; ALTERACOES CROMOSSOMICAS


105/163US=10 / Biol/Mol
Pelengaris S, Khan M. Apoptosis. In: ___. The molecular biology of cancer. Oxford: Blackwell, 2006. p. 251-78. ISBN 978-1-4051-1814-9.

FORMACAO DE CANCER; APOPTOSE CONTRA NECROSE; SUPRESSOR TUMORAL P53; MORTE CELULAR


106/163US=17 / Biol/Mol
Kiaris H. Genes involved in carcinogenesis: tumor-suppressor genes. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 27-39. ISBN 978-3-527-31486-7.

GENES SUPRESSORES DE TUMORES; HAPLOINSUFICIENCIA; REDE REGULATORIA P53


107/163US=17 / Biol/Mol
Kiaris H. Specific topics: carcinogenesis in vivo: animal models and basic approaches to generate genetically modified animals. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 136-59. ISBN 978-3-527-31486-7.

CARCINOGENESE IN VIVO; MODELOS ANIMAIS; CARCINOGENESE EM RATOS; CAMUNDONGOS TRANSGENICOS; ESTUDAR PROMOTORES; MUTACOES ESPECIFICAS; TUMORES PANCREATICOS; CANCER DE MAMA; NEUROFIBROMATOSE TIPO I; NEUROFIBROMATOSE TIPO II; TUMORES DO INTESTINO; MALIGNIDADES HEMATOPOIETICAS; MELANOMA; CAMUNDONGOS DEFICIENTES P53; INSTABILIDADE GENOMICA; INSTABILIDADE DE MICROSSATELITES; INSTABILIDADE CROMOSSOMICA; TELOMEROS; RECOMBINACAO MITOTICA; RECOMBINACAO ESPONTANEA; INFECCOES VIRAIS RESTRITOS


108/163US=2 / Mama
Kandioler D, Jakesk R. Tissue predictive biomakers: p53 as a prognostic and predicitive indicator. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 193-209. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4.

BIOMARCADORES PREDITIVOS; P53; INDICADOR DE PROGNOSTICO


109/163US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR


110/163US=2 / Biol/Mol
Speidel D, Deppert W. Oncogenes/tumor suppressor genes: p53-mediated apoptosis: a multifaceted story. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 515-35. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMOR; P53; APOPTOSE MEDIADA


111/163US=2-A / Biol/Mol
Bhojani MS, Laxman B, Ross BD, Rehemtulla A. Molecular diagnosis: molecular imaging in cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 703-27. ISBN 978-3-527-31237-5.

DIAGNOSTICO MOLECULAR; IMAGIOLOGIA MOLECULAR; CANCER; IMAGEM OPTICO; IMAGEM DE BIOLUMINESCENCIA; IMAGEM FLUORESCENTE; RESSONANCIA MAGNETICA; IMAGEM NUCLEAR; IMAGEM MULTIMODAL; BIOMARCADORES; P53; METASTASE; ANGIOGENESE


112/163US=2-A / Biol/Mol
Hammond EM, Papandreou I, Giaccia AJ. Cellular stress, DNA damage and repair: hypoxia in cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 777-98. ISBN 978-3-527-31237-5.

ESTRESSE CELULAR; DANO AO DNA; REPARO DO DNA; CANCER; HIPOXIA; HIF; P53; GENE SUPRESSOR DE TUMOR


113/163US=2-A / Biol/Mol
Kaina B, Roos W. Cellular stress, DNA damage and repair: apoptosis induced by DNA-damaging agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 799-821. ISBN 978-3-527-31237-5.

ESTRESSE CELULAR; DANO AO DNA; REPARO DO DNA; APOPTOSE INDUZIDA POR AGENTES; DANIFICACAO DO DNA; P53; CASPASE-2


114/163US=2-A / Biol/Mol
Stridh H, Bykov VJN, Selivanova G, Wiman KG. Molecular targets and therapeutics: cancer therapy by reactivation of the p53 apoptosis pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 891-912. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; CANCER. TERAPIA; REATIVACAO DA APOPTOSE; VIA P53; TERAPIA GENETICA


115/163US=2-A / Biol/Mol
Rieger J, Weller M. Molecular targets and therapeutics: exploiting apoptosis pathways for glioblastoma therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1033-48. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; VIAS DE APOPTOSE; GLIOBLASTOMA. TERAPIA; PROTEINA P53; FAMILIA BCL-2; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FOSFOINOSITIDE-3-KINASE


116/163US=2-A / Biol/Mol
Jendrossek V, Belka C. Molecular targets and therapeutics: radiation therapy and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1049-86. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RADIOTERAPIA; APOPTOSE; MORTE CELULAR; P53; CERAMIDA; NECROSE


117/163US=3 / Ginecologia
Thomas M, Pim D, Banks L. The role of the HPV E6 oncoprotein in malignant progression. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 115-31. ISBN 1-904455-04-2.

PAPILOMAVIRUS HUMANO; HPV; ONCOPROTEINA E6; TRANSFORMACAO CELULAR; ALVOS CELULARES; P53; ONCOPROTEINA VIRAL; EFETORAS DO APOPTOTICO; REGULACAO TRANSCRICIONAL SUBVERTIDO; PROTEINA E6; FAMILIA MAGI; MUPP1


118/163US=14 / Urologia
Cote RJ, Lerner SP, Datar RH. Bladder and upper tract cancer: molecula biology and prognostic markers in bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 385-401. ISBN 978-0-7817-4984-0.

BEXIGA; CANCER DO TRATO SUPERIOR; BIOLOGIA MOLECULAR; MARCADORES PROGNOSTICOS; CANCER DE BEXIGA; VIA P53; GENE RETINOBLASTOMA; CICLINAS; QUINASES DEPENDENTES DA CICLINA; INIBIDORES DE CDK; ANGIOGENESE; RECEPTORES DO FATOR DE CRESCIMENTO; METILACAO DO DNA


119/163US=61 / Câncer
DeLeo AB. The role of hormones, growth factors, and oncogenes: p53-based immunotherapy of cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 491-505. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

120/163US=79 / Imagem
Hall EJ, Giaccia AJ. Gene therapy. In: ___. Radiobiology for the radiologist. 6ª ed. Philadelphia: Lippincott Willians & Wilkins, 2006. p. 432-9. ISBN 978-0-78-17-4151-4.

TERAPIA GENICA; VETORES VIRAIS; TERAPIA DO GENE SUICIDA; VIRUS CITOTOXICOS; DEFICIENCIA DO P53; IMUNOLOGIA MOLECULAR; VACINA; GENES SUPRESSORES DE TUMOR; VIAS DE TRANSDUCAO DE SINAL


Primeira | Anterior | Próxima | Última